Argentina Mammography Market Trends and Insights
Growing Burden of Breast Cancer
Breast cancer incidence in Argentina has reached 73 cases per 100,000 women, while mortality stands at 17.6 per 100,000, making the disease the country’s most prevalent female cancer. Public-health economists estimate that enhanced screening and therapy could avert half of premature cancer deaths and raise national life expectancy by 10 months. Even after a decade of organized screening, 30% of new cases still present at late stages, underscoring a sizeable gap in diagnostic capacity that keeps hospitals and imaging centers upgrading equipment. Population aging will swell per-capita oncology spending by 70% between 2023 and 2050, reinforcing long-term demand for mammography systems. The concentration of both cancer incidence and medical infrastructure in Buenos Aires and Córdoba magnifies regional equipment needs.Technological Advancements in Digital & 3-D Imaging
Ten-year clinical evidence shows DBT detects 20-65% more invasive tumors and trims false-positive recalls from 10.6% to 7.2% relative to 2-D studies. A dataset of 272,938 screenings reported a 5.3% cancer-detection rate for DBT versus 4.0% for digital mammography, while advanced-stage findings fell sharply. Private clinics in Buenos Aires and Mendoza quickly translated these gains into new procurement cycles, often bundling AI-assisted image-analysis software that lifts detection a further 20%. This technical edge compresses replacement timelines for analog units and establishes new performance baselines influencing both public tenders and private upgrades.High Upfront Cost of 3-D Systems for Public Hospitals
A DBT console can cost USD 85,000-275,000, a formidable outlay for facilities financed by provincial budgets that devote limited capital to high-tech upgrades. Public health spending equals only 2.19% of GDP, and roughly 17 million Argentines remain uninsured, forcing policymakers to prioritize essential services over advanced imaging. Urban-rural resource imbalances further tilt allocations toward Buenos Aires, leaving provincial hospitals dependent on refurbished equipment or donor programs for modernization. As a result, analog and first-generation digital machines persist in many public sites, sustaining a two-tier care environment.Other drivers and restraints analyzed in the detailed report include:
- Expansion of National Breast-Cancer Screening Program
- Reimbursement for DBT Boosting Hospital Demand
- Roll-Out of Mobile Mammography Units in Rural Provinces
- Irregular Reimbursement Cycles in Public Healthcare
Segment Analysis
Digital platforms held 60.72% of Argentina mammography market share in 2025, reflecting decisive migration away from analog units. Hospitals and imaging centers underscore the clinical benefits of higher resolution and lower radiation, while software upgrades extend equipment life cycles. Analog machines remain common in smaller provincial hospitals but continue to lose ground as refurbished digital units become affordable during currency swings. The “Others” category - including contrast-enhanced mammography and breast-specific gamma imaging - records the fastest CAGR at 9.38%, suggesting experimentation beyond traditional x-ray modalities. Regulatory hurdles from ANMAT, such as Spanish-language labeling and certificate-of-free-sale requirements, raise entry barriers, favoring vendors with established local partners. Portable digital detectors, fitted into mobile vans serving remote provinces, demonstrate superior diagnostic yield compared with older computed-radiography plates, fostering a parallel mobile-screening market.Locally refurbished digital systems satisfy budget constraints for many public hospitals, providing compliant image quality without the premium price of new imports. Currency devaluation amplifies this value proposition and sustains a domestic refurbishment ecosystem that refurbishes, certifies, and services units originally sourced from high-income markets.
Complete Report Scope:
- By Product Type
- Digital Mammography Systems
- Analog Mammography Systems
- Others
- By Technology
- 2-D Full-Field Digital Mammography (FFDM)
- 3-D Digital Breast Tomosynthesis
- Phase-Contrast & Spectral Mammography
- By End-User
- Hospitals
- Diagnostic Imaging Centers
- Others
List of Companies Covered in this Report:
- Hologic
- GE Healthcare
- Siemens Healthineers
- Fujifilm Holdings Corp.
- Canon
- Koninklijke Philips
- Carestream Health
- Planmed
- IMS Giotto S.p.A.
- Metaltronica
- Samsung Medison Co. Ltd.
- Hitachi Ltd. (Medical Imaging)
- Agfa-Gevaert
- Koning
- Allengers Medical Systems Ltd.
- Analogic Corp. (BK Medical)
- Mindray
- Shimadzu
- Trivitron Healthcare
- Ziehm Imaging
Additional Benefits:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
Table of Contents
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Hologic Inc.
- GE Healthcare
- Siemens Healthineers AG
- Fujifilm Holdings Corp.
- Canon Medical Systems Corp.
- Koninklijke Philips N.V.
- Carestream Health Inc.
- Planmed Oy
- IMS Giotto S.p.A.
- Metaltronica S.p.A.
- Samsung Medison Co. Ltd.
- Hitachi Ltd. (Medical Imaging)
- Agfa-Gevaert N.V.
- Koning Corporation
- Allengers Medical Systems Ltd.
- Analogic Corp. (BK Medical)
- Shenzhen Mindray Bio-Medical Electronics Co. Ltd.
- Shimadzu Corp.
- Trivitron Healthcare
- Ziehm Imaging GmbH

